He's a professor of health policy at the Johns Hopkins Bloomberg School of Public Health and a Fox News medical contributor. MARTY MAKARY: Probably not because the J&J vaccine accounts for about 4% of all the vaccines administered. If you think about it, OxyContin was approved by the same person who's the acting commissioner now of the FDA. They may very well need this vaccine right now. There's people who are on the other extreme at the FDA, and there's a lot of opinions.

Source: Wall Street Journal April 18, 2021 14:37 UTC